The complete blood count (CBC) devices are used for screening of diseases during the medical assessment. These devices can be used for measuring red blood cells, platelets, hematocrit values and hemoglobin. These devices are portable and stationary, and these are used in diagnostics laboratories, hospitals, and other facilities for carrying out blood tests. CBC devices can be used to detect diseases like anemia, leukemia, blood infection and also helpful for monitoring glucose levels in diabetes patients.
The global complete blood count device market is expected to be valued at US$ 3,642.9 Mn in 2021, and is estimated to exhibit a CAGR of 8.3% during the forecast period (2021-2028).
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4974
Growing prevalence of blood infection is expected to propel growth of the global complete blood count device market during the forecast period. Rise in number of severe blood infection cases are driving the demand for blood count devices, further supporting growth of the market. For instance, in September 2020 the World Health Organization reported that 11 million individuals die due to sepsis every year, as sepsis occurs due to chemicals produced in bloodstream to tackle an infection cause inflammation all through the body.
Furthermore, rise in the number of product launches by the major players is also expected to fuel the growth of the global complete blood count device market during the forecast period. For instance, Beckman Coulter, a leading provider of medical devices in February 2021, announced the launch of its new hematology analyzer, DxH 560 AL developed to tackle limitations that small scale laboratories face regarding time and resources.
Impact of COVID-19:
The pandemic has affected many business including pharmaceuticals, biotechnology and clinical companies too. Due to disruption of various market activities including manufacturing, supply and distribution during this period, many industries faced hampered growth. However, rise in the number of COVID-19 patients and other chronic and life threating diseases is expected to increase the demand of CBC devices during the pandemic, as CBC is a standard test which is done to examine the quantity of red blood cells, white blood cells and all other components of the blood. It is used for examining the health of the infected person and not for COVID-19 test. Thus, this increased demand favorably affected the global complete blood count device market. The.
Increasing costs of CBC test and devices is anticipated to hamper growth of the global complete blood count device market during the forecast period. CBC test cost ranges from US$100 to US$1,000, depending on the insurance coverage, location and type of test.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4974
By Product Type:
- 3-Part Analyzer
- 5-Part Analyzer
- 6-Part Analyzer
By Test Type:
- White Blood Cell Count (WBC or leukocyte count)
- Red Blood Cell Count (RBC or erythrocyte count)
- WBC Differential Count
- Hemoglobin (Hbg)
- Hematocrit (Hct)
- Platelet Count
- Mean Platelet Volume (MPV)
- Mean Corpuscular Hemoglobin (MCH)
By End User:
- Research Institutes
- Diagnostic Laboratories
- North America
- Latin America
- Middle East
- Asia Pacific
Key players active in the global complete blood count device market are Danaher Corporation, Sight Diagnostics, Nihon Kohden Corporation, Abbott Laboratories, PerkinElmer, Inc, Sysmex Asia Pacific Pte Ltd, Company, Sight Diagnostics, bioMérieux SA, Siemens Healthineers, Bio-Rad Laboratories, Inc and Horiba.
Direct Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4974
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Complete Blood Count Device Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Complete Blood Count Device Industry Impact
Chapter 2 Global Complete Blood Count Device Competition by Types, Applications, and Top Regions and Countries
2.1 Global Complete Blood Count Device (Volume and Value) by Type
2.3 Global Complete Blood Count Device (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Complete Blood Count Device Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Complete Blood Count Device Market Analysis
Chapter 6 East Asia Complete Blood Count Device Market Analysis
Chapter 7 Europe Complete Blood Count Device Market Analysis
Chapter 8 South Asia Complete Blood Count Device Market Analysis
Chapter 9 Southeast Asia Complete Blood Count Device Market Analysis
Chapter 10 Middle East Complete Blood Count Device Market Analysis
Chapter 11 Africa Complete Blood Count Device Market Analysis
Chapter 12 Oceania Complete Blood Count Device Market Analysis
Chapter 13 South America Complete Blood Count Device Market Analysis
Chapter 14 Company Profiles and Key Figures in Complete Blood Count Device Business
Chapter 15 Global Complete Blood Count Device Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027